Publications by authors named "Anna Wainwright"

Claim this Profile
V
Vandetanib inhibits both VEGFR-2 and EGFR signalling at clinically relevant drug levels in preclinical models of human cancer.
Sandra R Brave, Rajesh Odedra, Neil H James, Neil R Smith, Gayle B Marshall, Anna Wainwright

Int J Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the activity of cediranib, a VEGFR-2/3 tyrosine kinase inhibitor, against VEGFR-1 and members of the structurally related PDGFR family.
Sandra R Brave, Kirsty Ratcliffe, Zena Wilson, Neil H James, Sue Ashton, Anna Wainwright

Mol Cancer Ther· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute pharmacodynamic and antivascular effects of the vascular endothelial growth factor signaling inhibitor AZD2171 in Calu-6 human lung tumor xenografts.
Neil R Smith, Neil H James, Ian Oakley, Anna Wainwright, Clive Copley

Mol Cancer Ther· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discrete expression of TRPV2 within the hypothalamo-neurohypophysial system: Implications for regulatory activity within the hypothalamic-pituitary-adrenal axis.
Anna Wainwright, A Richard Rutter, Guy R Seabrook, Kathryn Reilly, Kevin R Oliver

J Comp Neurol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature.
Kevin R Oliver, Anna Wainwright, Lars Edvinsson, John D Pickard, Raymond G Hill

J Cereb Blood Flow Metab· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis